Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. - Wikidata - awgldk - TriplyDB

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

http://www.wikidata.org/entity/Q34394665

about

Breast cancer risk factors The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk A genome wide study of genetic adaptation to high altitude in feral Andean Horses of the páramo The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers "Stop Ne(c)king around": How interactomics contributes to functionally characterize Nek family kinases Two decades after BRCA: setting paradigms in personalized cancer care and prevention Map making in the 21st century: charting breast cancer susceptibility pathways in rodent models.Clinical management of hereditary breast cancer syndromes.Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.A review of cancer risk prediction models with genetic variants.The SLC4 family of bicarbonate (HCO₃⁻) transporters.Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?Hereditary breast cancer: clinical, pathological and molecular characteristics.Reproducibility, performance, and clinical utility of a genetic risk prediction model for prostate cancer in Japanese.The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers: Implications for counseling.Common low-penetrance risk variants associated with breast cancer in Polish women.The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.Personalized medicine: new genomics, old lessons An epidemiological perspective of personalized medicine: the Estonian experience.Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers Breast cancer risks and risk prediction models.Common variants modify the age of onset for basal cell carcinomas in Gorlin syndrome.Genotype in BRCA-associated breast cancers Ten modifiers of BRCA1 penetrance validated in a Norwegian series Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.Common breast cancer susceptibility loci are associated with triple-negative breast cancer.Associations of immunity-related single nucleotide polymorphisms with overall survival among prostate cancer patients.Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.Effect of simultaneously replacing putative TM6 and TM12 of human NBCe1-A with those from NBCn1 on surface abundance in Xenopus oocytes

P2860

Q26777289-8B032B85-D405-4B96-B054-8ECA68809186 Q27003050-478C8F2C-E4E9-4596-A73B-BA24D6AA8E07 Q27008356-CEB9773A-9D04-4A47-A621-8915D88626DF Q28660894-9F96E2DF-27B7-4AB0-83B5-F3BAB7D1B095 Q30440948-4015AC7A-5582-4BC3-977D-8546DD227899 Q30513982-94BBADB8-2A08-42BF-9AD9-ACBB4F719D11 Q31001228-8FFEC23B-88AB-402C-AB60-18B86110E3F7 Q31139519-CC79A843-EE0A-4C0F-925A-0D2F5D950517 Q33614244-71CFFB80-A815-4B52-9232-B5197E2A8699 Q33728829-F4812DF1-B88C-40B6-9AD8-A521A0513BD4 Q33820594-107CEFD7-BC75-489A-A6D9-D6CD94403760 Q33908246-9D3569E6-ADBB-4C37-B083-1FDCDDD340C5 Q34167563-D68E3FB3-6471-419F-AB9F-936500E1B985 Q34213403-96A8C345-3BF1-414F-A8B1-778DE93A3518 Q34265269-3C38ABCB-9668-45AF-A7B5-1BE1B930D69A Q34333694-5030098F-A75B-4E53-A78B-3891229D83E4 Q34339960-478483F0-0DD1-4EAF-B4A9-A68E186425C1 Q34425230-83E4CA36-AC91-4C9F-8620-B6D1B7BBF712 Q34447165-DF57F5C6-D821-434C-8117-397E0BB8D7C6 Q34481713-EE947668-F40D-4C29-AC98-422FC94468AF Q34493797-BB4D87CD-572D-495E-9BEA-D36680B03059 Q34523801-01C4D41A-472A-44BB-A8C0-079232F6359B Q34973472-68EE32D0-A144-4272-A4C7-BB762933096E Q35074030-BA2916F1-9BE3-4891-8A31-AD63A8771356 Q35082635-D611B6A9-1685-4A5F-A5F7-1D89F2E54001 Q35086233-9C70FC90-8CF8-4F40-BB86-302696DB50D7 Q35119701-CD36EFD9-C757-46EF-BF95-4DF4E1307BD3 Q35263848-FBF00279-4FC0-4599-B80E-C1B7C1FF69B8 Q35382206-AA6FC076-0A8F-4571-8377-CAEEFBBFCB06 Q35399596-7760A792-6CF3-4B0A-B99C-32514524064C Q35477995-3B2F9A19-B987-4700-94E6-9A2CFEF32895 Q35624773-D5993B4E-94C6-406D-9BF9-3B2E957441D2 Q35686538-6C339F35-96B0-4DC3-8F69-8F948C221E8D Q35815958-4D02E598-CB85-42CD-8A54-565FD5070BF9 Q35870067-9F731A90-0C03-4DAB-B104-A33263002FC8 Q35889575-8A64539F-36B7-4722-8F0A-E83B5F53EFE4 Q35891162-8A5095A2-5599-44F9-942D-A2CECDDACD76 Q36046753-9A9520B6-27C9-415D-B1A9-74E7009AE8C5 Q36245609-C8BB126B-5050-4F0A-80B7-DDD758A0EB0C Q36257173-36EE7966-BA20-40EB-9CA2-E9D0D59949FC

P2860

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

http://www.wikidata.org/entity/Q34394665

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Common breast cancer susceptib ...... lications for risk prediction.

@ast

Common breast cancer susceptib ...... lications for risk prediction.

@en

Common breast cancer susceptib ...... lications for risk prediction.

@nl

type

label

Common breast cancer susceptib ...... lications for risk prediction.

@ast

Common breast cancer susceptib ...... lications for risk prediction.

@en

Common breast cancer susceptib ...... lications for risk prediction.

@nl

prefLabel

Common breast cancer susceptib ...... lications for risk prediction.

@ast

Common breast cancer susceptib ...... lications for risk prediction.

@en

Common breast cancer susceptib ...... lications for risk prediction.

@nl

P1433

Q34394665-5CB5CA1B-5E34-4E9F-B923-370A2BA460F1

P1476

Q34394665-E85D9156-317B-4291-B4AA-61D54753919B

P2093

Q34394665-00A3D4F2-5969-4B9C-9731-73629588A50F

Q34394665-027AF817-1C13-4246-972B-7232EA941954

Q34394665-03813513-E288-4C98-854D-D068411B4C93

Q34394665-044714B2-2EDF-41C6-B93A-DA111205CB25

Q34394665-04CE7575-FDA5-4723-BF11-88A0A4BDB689

Q34394665-05049821-973C-4216-9C7D-AE83023BDE4E

Q34394665-060EE55B-9C3A-428A-AE96-05CD7E34CF32

Q34394665-08C73F6E-8876-4D40-B3D9-F4D4DF872AF3

Q34394665-0C65E122-6417-4F4F-960A-728A6A00CFA4

Q34394665-18795FFF-28D7-4A04-A450-F434E1F62568

P2860

Q34394665-22AEA76A-2239-4E16-BDEC-FB89DF00A277

Q34394665-2C780651-1E68-4F0B-B598-DEB115E865A0

Q34394665-317B8EC3-F189-4E93-A776-F4D443E0F631

Q34394665-3826D8EF-7071-4AE1-9618-9CFECEC78777

Q34394665-3CE5831B-0409-463F-9B42-5F6568518A1B

Q34394665-42824B90-9241-4B52-9523-072A9494CA8D

Q34394665-4CE15244-9CEE-4B1D-992C-89C7C5AA4977

Q34394665-4E34C319-911A-43C9-A045-30352B2534C9

Q34394665-50A912A3-53F0-41ED-A22E-99EE0D35C540

Q34394665-650DCA61-9190-4F3B-84DE-BFEAFDFCD313

P304

Q34394665-50A1A1F8-E36F-44D3-8B32-685C78D6DEFD

P31

Q34394665-76E77E45-2317-45A1-A376-AFC0294922F4

P356

Q34394665-91DE10E8-AC1F-4ADC-A5C3-BFDEDDE29F49

P407

Q34394665-B16888CD-6471-4983-8990-4E9DEE62F2FC

P433

Q34394665-894FAA71-C2E8-4428-844E-A80982259FD7

P478

Q34394665-83BB1EBF-7A6C-4123-BEE8-6387D7C6D383

P50

Q34394665-06C7E46E-CD25-45AF-A734-5B384F3C6CB5

Q34394665-09E0A8B6-E51C-410F-B391-117E77E8A4EC

Q34394665-0C8E08E8-3767-4F6A-80FC-C609811D3A86

Q34394665-0CA2F2F4-AB0C-405E-8B20-1C9B2207D26A

Q34394665-0DA7BA71-9ED4-40D7-97FD-C79D15ABBCCD

Q34394665-2BD8E7FB-2104-40BB-97E6-B032458E8F30

Q34394665-2F975C71-82D7-4F58-8897-8F620E95986B

Q34394665-401CB147-E7BA-4486-B91B-476EEA72862F

Q34394665-4211B22E-BB52-4664-9B08-C3946FED901C

Q34394665-44269A13-6188-4348-BE07-2FDC9BBD4CDA

P577

Q34394665-027F78E7-85F2-417C-B4D6-741EE9EA8F48

P698

Q34394665-9512A4E2-B307-4CC1-A015-EB772F19FEE6

P932

Q34394665-78149E09-59FD-4C4E-A31E-500B6A0A9F2F

P356

0008-5472.CAN-10-1907

P1433

Cancer Research

P1476

Common breast cancer susceptib ...... lications for risk prediction.

@en

P2093

Agnès Hardouin

http://www.w3.org/2001/XMLSchema#string

Ake Borg

http://www.w3.org/2001/XMLSchema#string

Alexander Miron

http://www.w3.org/2001/XMLSchema#string

Ana Dutra-Clarke

http://www.w3.org/2001/XMLSchema#string

Andrew K Godwin

http://www.w3.org/2001/XMLSchema#string

Ania Jakubowska

http://www.w3.org/2001/XMLSchema#string

Anna Allavena

http://www.w3.org/2001/XMLSchema#string

Anne Catharina Dressler

http://www.w3.org/2001/XMLSchema#string

Antoine de Pauw

http://www.w3.org/2001/XMLSchema#string

Beatrice Melin

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Genome-wide association study identifies novel breast cancer susceptibility loci

Variation of breast cancer risk among BRCA1/2 carriers.

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

Overcoming the winner's curse: estimating penetrance parameters from case-control data.

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2.

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

Genome-wide association study identifies five new breast cancer susceptibility loci

P304

9742-9754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-1907

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Shirley Hodgson

Dominique Stoppa-Lyonnet

Georgia Chenevix-Trench

Rita Schmutzler

Kristiina Aittomäki

Heli Nevanlinna

P577

2010-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21118973

http://www.w3.org/2001/XMLSchema#string

P932

2999830

http://www.w3.org/2001/XMLSchema#string